Press-release for stocks publishing date 2022 - 02

publishing date : 2022 - 02 - 24 source : Www.biospace.com

save search

Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
VXRT | News | $0.7097 -4.79% -5.72% 1.4M

Health Technology

| -83.79% | O: -9.93% H: 0.0% C: 0.0%
financial results report results

Sangamo Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Business Highlights
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
SNYNF | News | $94.0 -0.27% -2.18% 310

Health Technology

| -8.91% | O: 0.78% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M

Health Technology

| -9.66% | O: -4.06% H: 0.0% C: 0.0%
SGMO | News | $0.493 -5.36% -6.07% 1.2M

Health Technology

| -90.89% | O: -2.04% H: 0.0% C: 0.0%
financial results therapeutics report results

Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
VIR | $8.04 -1.11% -1.12% 770K

Health Technology

| -71.08% | O: -6.87% H: 0.0% C: 0.0%
GILD | $67.08 0.08% 0.06% 6.2M

Health Technology

| 9.34% | O: -1.04% H: 0.0% C: 0.0%
ALNY | $143.8 -1.55% -1.58% 400K

Health Technology

| -2.49% | O: -2.95% H: 0.0% C: 0.0%
financial results technology report results biotech iot

Silk Road Medical Reports Fourth Quarter and Full Year 2021 Financial Results and Provides 2022 Financial Outlook
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
SILK | $17.57 -0.57% -0.51% 610K

Health Technology

| -39.91% | O: -5.64% H: 0.0% C: 0.0%
financial results report results

Applied Molecular Transport Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
AMTI 4 | $0.263 -14.3% -1.14% 0

Health Technology

| -95.78% | O: -4.01% H: 0.0% C: 0.0%
financial results report results molecular

Emergent BioSolutions Reports Financial Results for Fourth Quarter 2021
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology

| -8.11% | O: -1.05% H: 0.0% C: 0.0%
EBS | News | $2.18 -4.8% 3.21% 800K

Health Technology

| -94.87% | O: -1.65% H: 0.0% C: 0.0%
financial results solutions report results merge

MacroGenics Provides Update on Corporate Progress and 2021 Financial Results
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
PRVB | $24.98 0.08% 9.1M

Health Technology

| 289.7% | O: -8.35% H: 0.0% C: 0.0%
MGNX | $15.7 -3.27% -3.38% 520K

Health Technology

| 56.53% | O: -1.99% H: 0.0% C: 0.0%
IMGN | News | $31.23 0.03% 49M

Health Technology

| 552.19% | O: -2.3% H: 0.0% C: 0.0%
IMAB | $1.81 0.56% 0.28% 110K

Health Technology

| -92.48% | O: -5.2% H: 0.0% C: 0.0%
financial results results

Cyteir Therapeutics Announces the Appointment of Stephen Sands to Board of Directors
Published: 2022-02-24 (Crawled : 01:00) - biospace.com/
CYT | $3.02 2.65% 1M

Manufacturing

| -50.57% | O: -3.44% H: 0.0% C: 0.0%
ces therapeutics

LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
LIVN | $55.94 1.67% 1.63% 980K

Health Technology

| -23.64% | O: -0.44% H: 0.0% C: 0.0%
implant ces

Cardiff Oncology Reports Fourth Quarter and Full Year 2021 Results and Recent Highlights
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
LLY | News | $732.2 -1.81% -0.84% 1.7M

Health Technology

| 215.64% | O: -1.4% H: 0.0% C: 0.0%
CRDF | $4.18 0.24% -0.24% 300K

Health Services

| 55.97% | O: -5.22% H: 0.0% C: 0.0%
report results

Inogen Announces Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
INGN | $7.05 2.17% 1.85% 230K

Health Technology

| -74.91% | O: -0.93% H: 0.0% C: 0.0%
financial results ces results

Jasper Therapeutics Announces JSP191 Phase 1b MDS/AML Late Breaking Data Presentation at the 2022 Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
JSPR | $22.03 -0.36% -0.14% 45K

| 477.46% | O: 1.44% H: 0.0% C: 0.0%
jsp191 phase 1b therapeutics presentation cel phase 1 therapy aml phase 2b

Aerie Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
AERI | $15.25 0.0%

Health Technology

| 170.04% | O: -1.06% H: 0.0% C: 0.0%
als financial results report results

US FDA approves Jardiance® (empagliflozin) to treat adults with heart failure regardless of left ventricular ejection fraction
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
LLY | News | $732.2 -1.81% -0.84% 1.7M

Health Technology

| 215.64% | O: -1.4% H: 0.0% C: 0.0%
jardiance fda heart

PhaseBio Pharmaceuticals to Participate in the Cowen 42nd Annual Health Care Conference
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
PHAS | $0.0701 -23.97%

Health Technology

| -91.74% | O: 2.61% H: 0.0% C: 0.0%
health als conference

NanoString to Webcast Presentation from the 42nd Annual Cowen Health Care Conference
Published: 2022-02-24 (Crawled : 00:00) - biospace.com/
NSTG M | $0.1053 -37.43% -0.19% 0

Health Technology

| -99.65% | O: -3.52% H: 0.0% C: 0.0%
health conference presentation

US-Authorized COVID-19 Vaccines Generate More Than $30 Billion in 2021
Published: 2022-02-24 (Crawled : 23:00) - biospace.com/
JNJ | News | $148.53 -0.69% 0.18% 7.5M

Health Technology